The American Heart Association presented its 2017 Research Achievement Award to Thomas G. Brott, M.D., "for his pivotal role in the development of life-saving interventions that have revolutionized treatment of acute ischemic stroke, with enormous consequent benefits dramatically reducing stroke death and disability in the world's population."

Hospitals ranked among the best in cardiology and heart surgery by U.S. News and World Report appear no better at performing percutaneous coronary intervention (PCI), a potentially life-saving heart procedure, than unranked hospitals, according to preliminary research presented at the American Heart Association's Scientific Sessions 2017, a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.

The U.S. Food and Drug Administration expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood. Zelboraf is indicated to treat patients whose cancer cells have a specific genetic mutation known as BRAF V600. This is the first FDA-approved treatment for ECD.

Approximately 3.4 million Americans and over 60 million people worldwide are living with epilepsy, a condition marked by recurrent seizures. "Epilepsy is one of the most common neurologic illnesses that exist today and is a huge burden on quality of life," says Dr. William Tatum, neurologist at Mayo Clinic's campus in Jacksonville, Florida.

Reflecting on your education, you probably remember one or two extraordinary teachers who stand out. They were the instructors who were able to make dull subjects interesting or complex information easily understandable. They had the humor, empathy and passion for teaching that made you look forward to their classes.

Mayo Clinic's move toward a single, integrated electronic health record and billing system continues with the implementation of Epic at Mayo Clinic Health System sites in Minnesota.